For the Inventor, By the Inventor

Enter assignee name

Madison, WI, United States of America

Cellular Dynamics International, Inc.

USPTO Granted Patents = 29

EPO Patents = 15

Trademarks = 3

Forward Citations = 212

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Amanda Mack (9 out of 11 patents)

Deepika Rajesh (7 out of 17 patents)

Maksym A Vodyanyk (6 out of 23 patents)

4. Junying Yu (6 out of 15 patents)

5. Wen Bo Wang (6 out of 12 patents)

6. Casey Stankewicz (5 out of 8 patents)

7. Steven James Kattman (5 out of 7 patents)

8. Peter Fuhrken (5 out of 6 patents)

9. Nathaniel Beardsley (4 out of 6 patents)

10. James A Thomson (3 out of 81 patents)

11. Brad Swanson (3 out of 4 patents)

12. Nathan Meyer (3 out of 21 patents)

13. Matt Riley (3 out of 4 patents)

14. Christine Daigh (3 out of 3 patents)

15. Matthew George (2 out of 2 patents)

29 patents: Sort by Forward Citations

1. 12716058 - METHODS FOR DIRECTED DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO HLA HOMOZYGOUS IMMUNE CELLS (2026-08-25),

2. 9957482 - Cardiomyocyte production (2018-05-01),

3. 9694036 - Production of midbrain dopaminergic neurons and methods for the use thereof (2017-07-04),

4. 9644184 - Methods for the production of IPS cells using Epstein-Barr (EBV)-based reprogramming vectors (2017-05-09),

5. 9574179 - Hematopoietic precursor cell production by programming (2017-02-21),

6. 9506114 - Identifying genetic variation in affected tissues (2016-11-29),

7. 9487752 - Priming of pluripotent stem cells for neural differentiation (2016-11-08),

8. 9447382 - Generation of induced pluripotent stem cells from small volumes of peripheral blood (2016-09-20),

9. 9404122 - Endothelial cell production by programming (2016-08-02),

10. 9365827 - Cardiomyocyte production (2016-06-14),

11. 9365826 - Cardiomyocyte medium with dialyzed serum (2016-06-14),

12. 9347044 - Reprogramming T cells and hematopoietic cells (2016-05-24),

13. 9328332 - Methods for the production of IPS cells using non-viral approach (2016-05-03),

14. 9295697 - Episomal reprogramming with chemicals (2016-03-29),

15. 9260722 - Hepatocyte production by forward programming (2016-02-16),

Cellular Dynamics International, Inc. (CDI), a subsidiary of FUJIFILM Corporation, is a leading developer and manufacturer of human cells for a wide range of biomedical research applications. CDI leverages its technology platform to produce high-quality human induced pluripotent stem cells (iPSCs) and differentiated tissue-specific cells. These cells have various applications in drug discovery, regenerative medicine, and personalized medicine. CDI's innovative solutions enable researchers and pharmaceutical companies to access reliable and physiologically relevant human cell models, accelerating the development of safe and effective therapies. Visit their website for more information and to explore their products and services.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Cellular Dynamics International, Inc.

29 Patents

#32 in Madison, WI

#276 in Wisconsin

#11,598 in US

#22,493 in the World

Madison, WI, United States of America

Cellular Dynamics International, Inc.

Forward Citations = 212

42 inventors:

Amanda Mack (9 out of 11 patents)

Deepika Rajesh (7 out of 17 patents)

Maksym A Vodyanyk (6 out of 23 patents)

4. Junying Yu (6 out of 15 patents)

5. Wen Bo Wang (6 out of 12 patents)

Please report any incorrect information to [email protected]

Loading…